ArticleBMJ open2023

Study protocol of LANTana: a phase Ib study to investigate epigenetic modification of somatostatin receptor-2 with ASTX727 to improve therapeutic outcome with [177Lu]Lu-DOTA-TATE in patients with metastatic neuroendocrine tumours, UK.

Ravindhi Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.